| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1/2 | |||
| NCT05271318 | Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or… | Platinum-refractory Ovarian Carcinoma | Active, Not Recruiting |
| Phase 1 | |||
| NCT05222932 | Oncolytic Adenovirus TILT-123 and Avelumab for Treatment of Solid Tumors Refractory to or… | Melanoma | Active, Not Recruiting |
| NCT06125197 | Oncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Refractory Non-Small… | Lung Cancer | Active, Not Recruiting |
| NCT06961786 | TNFα and IL-2 Coding Oncolytic Adenovirus TILT-123 With Lymphocyte-depleting Chemotherapy… | Metastatic Melanoma | Active, Not Recruiting |